Revance Therapeutics Gross Profit (TTM) Analysis

Revance Therapeutics Inc (RVNC)

2.83 -0.06 (-2.08%) USD | NASDAQ | May 31, 16:00

2.83 0.00 (0.00%) After-Hours: 20:00

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	163.54M
December 31, 2023	159.80M
September 30, 2023	133.88M
June 30, 2023	114.80M
March 31, 2023	96.82M
December 31, 2022	80.90M
September 30, 2022	72.56M
June 30, 2022	68.14M
March 31, 2022	62.67M

Date	Value
December 31, 2021	54.39M
September 30, 2021	43.79M
June 30, 2021	32.68M
March 31, 2021	19.58M
December 31, 2020	10.56M
September 30, 2020	3.175M
June 30, 2020	0.471M
March 31, 2020	0.193M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

0.193M

Minimum

Mar 2020

163.54M

Maximum

Mar 2024

65.76M

Average

62.67M

Median

Mar 2022

Gross Profit (TTM) Benchmarks